ALUMIS
Alumis provides precision medicines. They transform the lives of patients with autoimmune diseases. They bring a proven track record in precision drug development of groundbreaking therapies. They rewrite the autoimmune treatment playbook with a unique precision analytics platform to advancing their understanding of immunologic diseases. They build a pipeline of therapeutics based on genetically validated targets for application in the treatment of multiple autoimmune disease indications.
ALUMIS
Industry:
Biotechnology Health Care Medical Precision Medicine
Founded:
2021-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.alumis.com
Total Employee:
11+
Status:
Active
Contact:
+1 650 231 6625
Email Addresses:
[email protected]
Similar Organizations
BlueRock Therapeutics
It is a regenerative medicine company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
CycloPure
CycloPure is a materials science company
GENE.AC
GENE.AC is a provider of domestic precision medicine solutions.
Gene Predictis
Gene Predictis is a Swiss precision medicine company.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Renerva
Renerva is a rapidly-growing and innovative medical device company.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
Stabiliz Orthopaedics
Stabiliz Orthopaedics develops novel enhancements for orthopedic medical devices using FDA-approved technologies.
ENU Nutrition
ENU Nutrition develops and commercializes nutritional products.
Current Employees Featured
Official Site Inspections
http://www.alumis.com
- Host name: ec2-34-192-255-123.compute-1.amazonaws.com
- IP address: 34.192.255.123
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149

More informations about "Alumis"
Alumis Inc. is focused on immune-mediated disease therapies
About Alumis. Our Pipeline. We strive to transform the treatment paradigm for people living with immune-mediated diseases by replacing broad immunosuppression with targeted therapies. โฆSee details»
Alumis - LinkedIn
Alumis Biotechnology Research South San Francisco, California 6,878 followers Transforming the lives of patients living with immune-mediated diseases using a precision approach.See details»
Alumis - Crunchbase Company Profile & Funding
Organization. Alumis . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Alumis is a precision medicines โฆSee details»
Alumis Org Chart + Executive Team - The Official Board
Organizational Chart of Alumis. Alumis Org Chart www.alumis.com. has 36 executives +1 484 216 0000; Add an executive. Alumis (ALMS) News . Anything missing? We search for you. Print or download . CEO & Chairman. Martin โฆSee details»
Alumis - Leadership Team - The Org
The Leadership Team at Alumis is responsible for setting the strategic direction of the company and ensuring the successful execution of its vision to transform the lives of patients with โฆSee details»
Corporate Presentation - investors.alumis.com
Alumis assumes no obligation and does not intend to update these forward-looking statements, even if new information becomes available in the future, except as required by law. This โฆSee details»
Alumis - The Org
At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. We recognize that patients living with immune โฆSee details»
Alumis - Contacts, Employees, Board Members, Advisors & Alumni โฆ
Alumis is a precision medicines company. New. Resources. Advanced Search. Start Free Trial ... Experience the new Crunchbase, powered by AI . Experience the new Crunchbase, powered โฆSee details»
Alumis Strengthens Leadership Team with Key Appointments
Jan 28, 2025 Alumisโ most advanced product candidate, ESK-001, is an oral, highly selective, small molecule, allosteric inhibitor of tyrosine kinase 2 that is currently being evaluated for the โฆSee details»
ALMS - Alumis Inc. | Company Profile | OTC Markets
Feb 27, 2025 Alumis Inc. 280 East Grand Avenue. South San Francisco, CA 94080 . www.alumis.com (650) 231-6625. [email protected]. Business Description. Alumis Inc., a โฆSee details»
Approach at Alumis Inc.
Our Approach. At Alumis, our driving principle is to deliver the right medicine to achieve the best possible clinical outcome. To realize that goal, we are using our precision approach to โฆSee details»
Alumis - Crunchbase Company Profile & Funding
Organization. Alumis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Alumis is a precision medicine company focused โฆSee details»
Alumis and ACELYRIN Reaffirm Strategic and Financial Rationale of ...
Mar 4, 2025 Alumis and ACELYRIN and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. โฆSee details»
Alumis and ACELYRIN Announce Amended Merger Agreement
Apr 21, 2025 Alumis Contacts Investor Relations Teri Dahlman Red House Communications [email protected] Or MacKenzie Partners, Inc. [email protected] (800) โฆSee details»
How Much Did Alumis Raise? Funding & Key Investors
What Is Alumis? Alumis, founded in 2021, is a biotechnology company based in San Francisco, California. The company operates in the biotechnology, healthcare, life science, and precision โฆSee details»
Alumis Company Profile - Office Locations, Competitors, Revenue โฆ
Oct 29, 2024 Alumis (formerly known as Esker Therapeutics) is a clinical-stage biopharmaceutical company developing oral therapies. It specializes in the discovery, โฆSee details»
Alumis Strengthens Leadership Team with Key Appointments
Jan 28, 2025 About Alumis Alumis is a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly โฆSee details»
Alumis | Piper Sandler
Alumis is a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with โฆSee details»
Alumis - workinbiotech.com
Alumis is using precision medicine to find effective treatment for patients with autoimmune disorders. Despite the advances made in treatments in the past decade, patients with โฆSee details»
News Releases - Alumis Inc.
Alumis Inc. 280 East Grand Avenue South San Francisco CA 94080 (650) 231-6625See details»